PMID: 7086124Jan 1, 1982Paper

Specific activity of concentrated and purified cell culture rabies vaccine (CPCRV) from the strain Vnukovo -32-107 in an experiment with therapeutical immunization of humans

Journal of hygiene, epidemiology, microbiology, and immunology
M SelimovA Pyaeva

Abstract

Reactogenicity and specific activity of three series of concentrated and purified cell culture rabies vaccine (CPCRV) were studied in an experiment of therapeutical immunization of 300 human subjects bitten by domestic animals, category "C". CPCRV was well tolerated; when administered intramuscularly, it did not provoke local reactions, while general reactions, such as temporary headaches and indisposition, were observed in 4% of cases. Intradermal revaccination with CPCRV was followed by local reactions in 73.6% of cases. Such a reaction can be regarded as a cutaneous allergic test. Coded paired sera of 263 subjects were examined in the neutralization reaction on mice. After primary intramuscular immunization, antibody titres were found to be very low. Relatively high titres of antibodies and 100% seroconversion were recorded after a single intramuscular or intradermal revaccination with CPCRV. Relatively high antibody titres and 100% seroconversion also resulted from treble, and especially quadruple primary intramuscular immunization using a dose of 1.5 ml on days 0, 8, 16, 24 or 0, 8, 16 and 32. When treating bites of non-dangerous localization, CPCRV can be administered in a dose of 1.5 ml at a time on days 0, 7 15, 30 and ...Continue Reading

Related Concepts

Antibodies, Viral
Immunization Schedule
Rabies (Disorder)
Rabies Vaccines
Rabies virus
Vaccination

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Generating Insulin-Secreting Cells

Reprogramming cells or using induced pluripotent stem cells to generate insulin-secreting cells has significant therapeutic implications for diabetics. Here is the latest research on generation of insulin-secreting cells.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Epigenome Editing

Epigenome editing is the directed modification of epigenetic marks on chromatin at specified loci. This tool has many applications in research as well as in the clinic. Find the latest research on epigenome editing here.